Yes, COPD can cause heart failure, and it does so more often than many people realize. Roughly 1 in 5 people with stable COPD have unrecognized heart failure that has never been formally diagnosed. The connection runs through several pathways, affecting the right side of the heart first but eventually involving the left side as well.
How COPD Damages the Heart
The lungs and the heart share a circulation loop. The right side of your heart pumps blood into the lungs to pick up oxygen, and healthy lungs offer relatively little resistance to that blood flow. COPD changes the equation. When lung tissue is chronically inflamed and damaged, the small blood vessels within the lungs narrow, stiffen, and in some cases are destroyed entirely. This forces the right side of the heart to pump harder to push blood through a shrinking network of vessels.
The process starts with low oxygen levels. When parts of the lung aren’t getting enough air, the blood vessels in those areas constrict automatically, a reflex meant to redirect blood toward healthier tissue. In COPD, where large portions of the lung are affected, this constriction happens across a wide area and becomes persistent. Over time, the vessel walls thicken physically: the inner lining swells, the muscular layer grows, and even the smallest blood vessels develop muscular walls they wouldn’t normally have. The result is a sustained rise in blood pressure inside the lungs, a condition called pulmonary hypertension.
Several chemical changes make this worse. Damaged lung tissue releases less of the substances that normally keep blood vessels relaxed, while producing more of the compounds that promote constriction and inflammation. Oxidative stress and chronic inflammation drive ongoing remodeling of the vessel walls, creating a cycle where higher pressures cause more structural damage, which raises pressures further.
Right-Sided Heart Failure and Cor Pulmonale
The right ventricle is built for a low-pressure system. It has thinner walls than the left ventricle because, under normal conditions, it doesn’t need much force to move blood through the lungs. When pulmonary hypertension raises the resistance, the right ventricle compensates by thickening its walls, similar to how a bicep grows when you lift heavier weights. This is called right ventricular hypertrophy.
Eventually the muscle can’t keep up. The right ventricle stretches and dilates, losing pumping efficiency. Blood backs up into the veins, causing swollen ankles and legs, an enlarged liver, and fluid buildup in the abdomen. This specific pattern of right-sided heart failure caused by lung disease is called cor pulmonale, and COPD is its most common cause. The severity of cor pulmonale tracks closely with how low a person’s oxygen levels drop, how much carbon dioxide builds up in their blood, and how obstructed their airways are.
Research using echocardiography has found that right ventricular changes, including reduced pumping ability, thickening, and dilation, can appear even when pulmonary pressures are only mildly elevated. This means the heart may start struggling earlier in the course of COPD than doctors once assumed.
COPD Also Affects the Left Side of the Heart
The connection doesn’t stop at the right ventricle. Right-sided heart failure is associated with left-sided heart failure, and COPD appears to affect the left ventricle through its own mechanisms as well.
COPD is not just a lung disease. It triggers a body-wide inflammatory response. Damaged airways release inflammatory proteins into the bloodstream, including C-reactive protein, fibrinogen, and several signaling molecules that promote inflammation in blood vessel walls throughout the body. This systemic inflammation contributes to atherosclerosis (artery hardening) and can directly impair the left ventricle’s ability to contract and relax properly.
Shared risk factors compound the problem. Smoking damages both the lungs and the cardiovascular system. Advanced age, a sedentary lifestyle, and the deconditioning that comes with chronic breathlessness all add to cardiovascular strain. Studies using echocardiography have found that left ventricular pumping function in COPD patients correlates with their lung function and exercise capacity, meaning that as COPD worsens, the left side of the heart tends to weaken in parallel. These changes can begin before heart failure becomes clinically obvious.
Why Heart Failure Often Goes Undetected in COPD
The biggest diagnostic challenge is that COPD and heart failure share their cardinal symptom: shortness of breath. Both conditions also cause fatigue, reduced exercise tolerance, and in advanced stages, fluid retention. When someone with known COPD becomes more breathless, it’s natural for both the patient and their doctor to attribute it to worsening lung disease. Community studies have found that about 20.5% of older adults with stable COPD have heart failure that hadn’t been diagnosed, suggesting this overlap leads to significant underrecognition.
Certain symptoms lean more toward heart failure than a COPD flare-up. Breathlessness that worsens when lying flat (and improves when you sit up or prop yourself on pillows) is more characteristic of heart failure. Waking up in the middle of the night gasping for air is another hallmark. Sudden, unexplained weight gain from fluid retention, persistent swelling in both legs, and a need to sleep propped upright are all signals that the heart may be involved rather than the lungs alone.
A blood test measuring a hormone released when the heart muscle is stretched can help sort things out. In COPD patients, levels below 400 pg/mL make heart failure unlikely, while levels above 2,000 pg/mL make it very likely. The middle range is less clear because right ventricular strain from COPD alone can moderately elevate these levels. An echocardiogram, which uses ultrasound to visualize the heart’s structure and pumping function, is the most practical tool for confirming whether heart failure is present and whether it involves the right side, the left side, or both.
How Combined COPD and Heart Failure Affects Survival
Being diagnosed with heart failure on top of COPD substantially raises mortality risk. Patients with both conditions face more than triple the one-year death rate compared to those with COPD alone, and roughly double the mortality at five and ten years. These numbers have remained stubbornly consistent over time. A UK study comparing outcomes across a decade found no improvement in survival for COPD patients who developed heart failure, even in more recent years, highlighting how difficult the combination is to manage.
Managing Both Conditions Together
One of the most important treatment considerations involves a class of heart medications that slow the heart rate and reduce its workload. These drugs are a cornerstone of heart failure treatment and have a proven mortality benefit, but they’ve traditionally been considered risky for COPD patients because of concerns that they might tighten the airways and worsen breathing. A review of 22 randomized controlled trials has largely put that concern to rest. Heart-selective versions of these medications did not reduce lung function or cause respiratory symptoms in COPD patients, even in those with severe airway obstruction. They were also well tolerated in patients who had both COPD and cardiovascular conditions like heart failure, angina, or high blood pressure.
This is clinically important because withholding effective heart failure treatment out of fear of lung side effects can worsen outcomes for people who already face a difficult prognosis. The current evidence supports using heart-selective formulations in COPD patients who need them, though the choice of specific medication and dose is tailored to each person’s situation.
Beyond medications, managing both conditions involves optimizing oxygen levels (since low oxygen is the primary driver of pulmonary hypertension), maintaining physical activity within tolerable limits, pulmonary rehabilitation, and close monitoring for fluid retention. Because the symptoms of COPD and heart failure mimic each other so closely, people with COPD benefit from periodic heart evaluations, particularly if breathlessness worsens in ways that don’t respond to their usual lung treatments or if new symptoms like leg swelling or nighttime breathlessness appear.